Ferritin nanocages: a novel platform for biomedical applications.

Area of Science:

• Biotechnology
• Nanomedicine
• Biochemistry

Background:

• Ferritin is a natural iron storage protein crucial for cellular iron homeostasis and protection against oxidative damage.
• Ferritin protein cages serve as versatile platforms for synthesizing nanoparticles and as nanocarriers in various applications.
• A significant challenge in cancer therapy and diagnosis is the absence of effective non-viral carriers for targeted drug and imaging agent delivery.

Purpose of the Study:

• To review the application of ferritin nanocages as novel non-viral nanocarriers for cancer therapy.
• To highlight the diverse biomedical applications of ferritin nanocages in cancer diagnosis and treatment.

Main Methods:

• Exploration of ferritin's pH-dependent reversible assembly/disassembly for drug and probe encapsulation.
• Investigation of ferritin's surface modifiability for attaching tumor-specific targeting moieties.
• Review of studies demonstrating ferritin's utility in targeted cancer diagnosis and therapy.

Main Results:

• Ferritin nanocages demonstrate pH-dependent encapsulation of anticancer drugs and imaging probes.
• The external surface of ferritin is amenable to chemical and genetic modification for targeted delivery.
• Ferritin nanocages exhibit biocompatibility, protecting cargo without eliciting toxic or immunogenic responses.

Conclusions:

• Ferritin nanocages represent a promising multifunctional nanocarrier for targeted cancer therapy and diagnosis.
• Their biocompatibility and modifiable nature make them ideal for developing advanced cancer treatment strategies.
• Ferritin nanocages offer a novel non-viral approach to overcome limitations in current cancer care.